Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

GREY:IMVIF - Post Discussion

IMV Inc > Another Ball dropped
View:
Post by QM4455 on Feb 23, 2021 10:52am

Another Ball dropped

I'll make this brief.
(I can't post under  my old account, stockhouse got some issues) 

Once again count on Ors and Labbe to do..... NOTHING. 

The stock had a nice run up past $4US, breaking the lower lows pattern in effect for the last few years and  there was a nice bid to IMV for a brief moment.  Instead of capitalizing on that  our dear mngmt dropped the ball again by delivering nothing as they have for the better part of last year. 

I am going to stick around for one more month and see if they can deliver on ANY of the many milestones promissed for this quarter, but I am not holding my breath. 

Overall, this management team went from competent if not stellar few years back to inept today. 

When poorly managed biotechs such us ONC outperform IMV that tells you something. 

Such a shame these guys can't get their act together given the strength of the platform. 

As for VR leaving I don't blame them. They got in on vaccine play back in March, rode the train. IMV delivered ZERO on Covid side so they bailed. 

They were never here for oncology, still, loosing institutional support is never helpful. 
Another strike against Ors and Co for not able to keep them around.
Comment by alphaseeking001 on Feb 23, 2021 11:33am
Thanks for chiming in QM45.  I, for one, always appreciate your input.  You seemed quite positive back in December after the DLBCL data and the quarter isn't over yet.  It seems (like many of us) that you are a little less positive now on the company and it's prospects?  I was feeling quite good about IMV after the most recent oncology updates and was less concerned ...more  
Comment by Hideaway on Feb 23, 2021 12:03pm
QM's comments are spot on. Too bad this management team could not have been more skillful in meeting expectations. I ,also, am staying put until the expected updates over the next five weeks but if they fail us once again then it is time to move past the great science and depart for greener pastures.Based on past experience, it probably is'nt the best strategy to wait but the monry ...more  
Comment by alphaseeking001 on Feb 23, 2021 1:03pm
Thanks for the input Hideaway and Europe.  Much appreciated.
Comment by QM4455 on Feb 23, 2021 1:05pm
Yes I was Alpha,  But you have to be able to seperate science from investement. Mr. Pemberton died peniless from his Coca-Cola invention...  If they got the updates out or some progress regarding Covid during this market run up, I'd be more optimistic, but in investing TIMING is EVERYTHING, and their timing for the last three years is hopeless.  If there is a general market ...more  
Comment by alphaseeking001 on Feb 23, 2021 1:21pm
Thanks again QM45! I seriously hope they deliver soon.  
Comment by qwerty22 on Feb 23, 2021 2:37pm
They don't need VR at this point to prove anything, they need to make solid progress with the regulators. I'm happy if 100% of their attention is on that.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities